Tempus AI

HIRING · 1 OPEN AI

About

Build, maintain and scale data pipelines and models that power analytics, reporting, and self-service exploration.
Collaborate with BI engineers, product managers, and engineering teams to translate business needs into reliable data solutions.
Support data governance, including data quality monitoring and audits.
Contribute to the evolution of the BI data platform by applying best practices in data modeling, orchestration, and governance.
Investigate and resolve complex data issues in par...

Tempus AI

About

Updates & Highlights

Tempus AI (NASDAQ: TEM) holder files to sell 250,000 Class A shares

Tempus AI (NASDAQ:TEM) Hits New 52-Week Low - Time to Sell?

Tempus AI Inc stock hits 52-week low at 41.7 USD

Recent Openings

Data Scientist II, Real World Evidence (RWE), Pharma R&D

All Jobs

Data Scientist II, Real World Evidence (RWE), Pharma R&D

Culture & Mission

Benefits & Perks

Equity/Stock Options

Health Insurance

Remote Work

Learning Budget

Competitive Salary

Generous PTO

Tech Stack

Core Values

Innovation

Collaboration

Excellence

Impact

Office Locations

Team

Are you on the team at Tempus AI?

News & Press

Tempus AI (NASDAQ: TEM) holder files to sell 250,000 Class A shares

Tempus AI (NASDAQ:TEM) Hits New 52-Week Low - Time to Sell?

Tempus AI Inc stock hits 52-week low at 41.7 USD

Eagle Health Investments LP Takes Position in Tempus AI, Inc. $TEM

Tempus AI Stock (TEM) Opinions on Personalis Acquisition and Analyst Upgrades

Tempus AI to Acquire Personalis in $1.5 Billion Deal, Deepening Its Foothold in Cancer Monitoring

Alan Tan: Highlighting Ultrasensitive MRD Detection with Tempus AI at KCRS26

136,636 Shares in Tempus AI, Inc. $TEM Acquired by Aristotle Atlantic Partners LLC

Tempus AI (NASDAQ:TEM) Upgraded to Hold at Wall Street Zen

Tempus AI buys Personalis for $1.5B; UCSF Health, Kleiner Perkins and Doerr Capital launch health AI accelerator; Candid Health raises $120M

Tempus AI Stock Before Q2 Earnings Release: To Buy, Hold or Sell?

Tempus AI Stock Before Q2 Earnings Release: To Buy, Hold or Sell?

Tempus AI stock: H.C. Wainwright reiterates Buy on MRD expansion

Personalis (PSNL) Agrees To Tempus AI Deal As Shareholder Fairness Review Begins

Tempus AI to Acquire Cancer Detection Platform Personalis

Tempus AI (TEM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Tempus AI Expands Cancer Platform With Launch of ArteraAI Prostate Test For Metastatic Patients

Tempus AI Makes Billion-Dollar Bet on the Future of Cancer Monitoring

Why is Tempus AI stock sliding today?

Tempus AI launches pharmacogenomics testing nationwide